Compare CCI & IDXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCI | IDXX |
|---|---|---|
| Founded | 1994 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.8B | 43.6B |
| IPO Year | 1998 | 1996 |
| Metric | CCI | IDXX |
|---|---|---|
| Price | $84.33 | $541.31 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 9 |
| Target Price | $104.69 | ★ $721.67 |
| AVG Volume (30 Days) | ★ 4.2M | 576.1K |
| Earning Date | 04-22-2026 | 05-05-2026 |
| Dividend Yield | ★ 4.95% | N/A |
| EPS Growth | ★ 111.25 | 22.59 |
| EPS | 0.34 | ★ 3.47 |
| Revenue | $4,264,000,000.00 | ★ $4,303,702,000.00 |
| Revenue This Year | N/A | $10.88 |
| Revenue Next Year | $1.72 | $8.59 |
| P/E Ratio | $244.47 | ★ $157.27 |
| Revenue Growth | N/A | ★ 10.42 |
| 52 Week Low | $75.96 | $507.55 |
| 52 Week High | $115.76 | $769.98 |
| Indicator | CCI | IDXX |
|---|---|---|
| Relative Strength Index (RSI) | 39.58 | 42.69 |
| Support Level | $84.29 | $523.38 |
| Resistance Level | $89.76 | $587.04 |
| Average True Range (ATR) | 2.66 | 15.84 |
| MACD | -1.12 | -1.90 |
| Stochastic Oscillator | 24.02 | 4.72 |
Crown Castle owns or manages roughly 40,000 wireless towers in the United States. It leases space on its towers to wireless service providers, which install equipment to support their wireless networks. The company has a very concentrated customer base, with about 90% of its revenue from the Big Three US mobile carriers: Verizon, T-Mobile, and AT&T. Crown Castle has plans to divest its fiber business, which is expected to be finalized in the first half of 2026. After that, it will be a stand-alone tower operator. Crown Castle operates as a real estate investment trust.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.